Know Cancer

or
forgot password


N/A
30 Years
90 Years
Not Enrolling
Male
Bladder Cancer

Thank you

Trial Information


Inclusion Criteria:



- Recurrent transitional cell carcinoma of urinary bladder post endoscopic resection

- PSA Prior synergo therapy application<10

- Normal rectal examination

- Patients willing to sign informed consent according

Exclusion Criteria:

- History of prostate cancer

- Previous history of TCC stage T2 or higher

- Invasive tu of bladder

- Prior pelvic radiotherapy or systemic chemotherapy

- Active prostatitis

- Active tuberculosis

Type of Study:

Observational

Study Design:

Time Perspective: Prospective

Principal Investigator

PEREZ DORON, M.D.

Investigator Role:

Principal Investigator

Investigator Affiliation:

HAEMEK MEDICAL CENTER, UROLOGY DEPARTMENT

Authority:

Israel: Ethics Commission

Study ID:

0034-07-EMC

NCT ID:

NCT00491296

Start Date:

June 2007

Completion Date:

June 2007

Related Keywords:

  • Bladder Cancer
  • S/P Transuretral resection of bladder tumor
  • Recurrent tumor after BCG Treatment
  • Urinary Bladder Neoplasms

Name

Location